Creyon Bio
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3210 Merryfield Row, San Diego, Californ...Website
www.creyonbio.comRevenue
$5.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Creyon Bio
Creyon Bio is a pre-clinical stage company reimagining drug development as it should be, using a data-first approach for generating uniquely powerful datasets and developing machine learning models to uncover the engineering principles that make precision oligonucleotide-based medicines possible for patient populations of all sizes.Explore more
Creyon Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Creyon Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Creyon Bio is spiking on competitors!
Earning: See what the market has to say on Creyon Bio recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Creyon Bio
Website visits: Recent activity has been detected on your website
Check if Creyon Bio has recently received funding, and reach out quickly before it becomes old news!
Click to see if Creyon Bio had a recent Job posting/layoffs
Product Launch: Get notified when Creyon Bio launches new products
Creyon Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Creyon Bio has new funding data
Recommended Actions
Find VP level buyers at Creyon Bio
Find 2 more new buyers
Compare Similar Companies to Creyon Bio
Compare insights from companies similar to Creyon Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Creyon Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Creyon Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Creyon Bio.
Creyon Bio financials insights
Gather financial insights about Creyon Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series A
$40M
Creyon Bio Tech Stack
A closer look at the technologies used by Creyon Bio
Most Recent Scoops
Executive Move
Executive Moves, Board of Directors
Promotion
Executive Move
Executive Moves, Promotion
Event
Person-Based
Christopher Hart, Co-Founder & Chief Executive Officer & President, appeared on a podcast called "The Tech Talks Daily Podcast" on 09/06/2024. Topics discussed include AI, drug development, personalized medicine, rare diseases.
Events, Podcast
Project
Engineering, Machine Learning, Product Management, Intellectual Property, Legal Affairs, Software, Medical Research, Artificial Intelligence, Healthcare Technology, Regulations
New Hire
Executive Move
Creyon Bio News & Media
Creyon Bio and Lilly Enter into RNA-Targeted Oligo Therapy Development Collaboration
SAN DIEGO--(BUSINESS WIRE)-- #AIinHealthcare--Creyon Bio, Inc. (“Creyon”) today announced a global licensing and multi-target research collaboration with Eli Lilly and Company (“Lilly”) focused on the discovery, development and commercialization of novel RNA-targeted oligonucleotide (oligo) therapies for a broad range of diseases. As a part of the collaboration, Creyon will leverage its industry-first AI-Powered Oligo Engineering Engine to design and optimize new drug candidates for Lilly’s nameCreyon Bio Appoints Industry Leader, Serge Messerlian as CEO, Leveraging Decades of Company Building and Strategic Collaborations
SAN DIEGO--(BUSINESS WIRE)-- #BiotechLeadership--Creyon Bio, Inc. ("Creyon") today announced the appointment of industry leader, Serge Messerlian as Chief Executive Officer, effective immediately. Mr. Messerlian brings Creyon Bio a track record in both multinational pharmaceutical and biotechnology leadership as well as company building and strategic collaborations across a range of disease areas including hematology, oncology, immunology, and rare diseases as well as novel technology platforms.Creyon Bio Appoints Venture Capitalists Serge Messerlian and Shaquille Vayda to Board of Directors
SAN DIEGO and RESEARCH TRIANGLE PARK, N.C., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Creyon Bio, Inc. ("Creyon"), a clinical-stage leader in AI/machine learning-enabled engineering of oligonucleotide-based medicines (OBMs), has appointed two prominent venture capitalists, Serge Messerlian, Operating Partner at DCVC Bio, and Shaquille Vayda, Principal at Lux Capital to serve on its Board of Directors.Creyon Bio Granted Second U.S. Patent for AI/Machine Learning-Enabled Oligonucleotide-Based Medicine Engineering Platform
Patent protects Creyon™ Platform’s proprietary method for rapid engineering and optimization of therapeutic oligonucleotides with AI/ML, accelerating development timelines
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Creyon Bio
Sign Up For FreeTo access detailed company insights
Creyon Bio is a pre-clinical stage company reimagining drug development as it should be, using a data-first approach for generating uniquely powerful datasets and developing machine learning models to uncover the engineering principles that make precision oligonucleotide-based medicines possible for patient populations of all sizes.... Read More
